Clinical Trials

Alzheimer's Disease Clinical Trial
Principal Investigator: Paul Rosenberg, MD

Our team seeks volunteers with Alzheimer's disease (AD), ages 50-90 years old, to participate in a study funded by GlaxoSmithKline. Mild-to-moderately impaired patients with AD who are on a stable dose of Aricept for at least 6 months and are not taking Namenda or medications for type 2 diabetes are eligible. Some of the patients will get the actual medication and some will get a placebo (sugar pill). Participants will have regular clinic visits as well as telephone contact for approximately 1 year. Biological specimens will be taken at regular intervals. The study is designed to see if a drug called Rosiglitazone will increase insulin in nerve cells, which may help to protect them, and thereby slow cognitive decline.

To learn more, please call Dr. Rosenberg at 410.955.6158